Diabetes Trials

  • 01/10/2018

    NGM217

    A Phase 1 Randomized Double-Blind Placebo Controlled Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of NGM217 in Adults with Autoimmune Diabetes

    View Trial
  • 31/10/2018

    EXTOD Mechanisms study

    Exploring the effect of exercise on immune function and beta cell health in patients with type 1 diabetes mellitus

    View Trial
  • 31/12/2019

    ADDRESS-2

    An incident and high risk type 1 diabetes research cohort – After Diagnosis Diabetes REsearch Support System-2

    View Trial
  • 31/12/2014

    PrePOINT (Primary Oral Insulin Trial)

    A dose-finding safety and immune efficacy study for primary mucosal insulin therapy in islet autoantibody negative children at high genetic risk for type 1 diabetes

    View Trial
  • 01/08/2016

    TrialNet Oral Insulin Study

    Oral Insulin for Prevention of Diabetes in Patients At Risk for Type 1 Diabetes Mellitus

    View Trial
  • 01/09/2019

    TrialNet LIFT Study

    Long Term investigative Follow-up in TrialNet (LIFT)

    View Trial
  • 01/09/2016

    Is intermittent cycle training an efficient and effective form of exercise for people with type 1 diabetes?

    View Trial
  • 01/05/2021

    Defining islet antigens to understand the immunology and for immunotherapy of type 1 diabetes

    View Trial
  • 31/05/2018

    CARMELINA

    A multicenter international randomized parallel group double blind placebo-controlled Cardiovascular Safety & Renal Microvascular
    outcomE with LINAgliptin 5 mg once daily in patients with type 2 diabetes mellitus at high vascular risk.

    View Trial
  • 31/10/2021

    SLEEP T2D Trial

    The Impact of Sleep Disorders in Patients with Type 2 Diabetes: A Cohort Study and Feasibility RCT

    View Trial